The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ocular Therapeutix Inc shares valued at $26,561 were sold by Heier Jeffrey S. on Nov 25 ’24. At $9.01 per share, Heier Jeffrey S. sold 2,948 shares. The insider’s holdings dropped to 269,059 shares worth approximately $2.55 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kaiser Peter sold 2,897 shares, netting a total of over 26,102 in proceeds. Following the sale of shares at $9.01 each, the insider now holds 213,087 shares.
Before that, Nayak Sanjay had sold 1,814 shares from its account. In a trade valued at $16,326, the Chief Strategy Officer traded Ocular Therapeutix Inc shares for $9.00 each. Upon closing the transaction, the insider’s holdings decreased to 1,814 shares, worth approximately $1.65 million.
As published in their initiating research note from Scotiabank on October 16, 2024, Ocular Therapeutix Inc [OCUL] has been a Sector outperform. Analysts at TD Cowen upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid June. Earlier on February 09, 2024, BofA Securities initiated its rating. Their recommendation was “a Buy” for OCUL stock.
Analyzing OCUL Stock Performance
During the last five days, there has been a drop of approximately -2.77%. Over the course of the year, Ocular Therapeutix Inc shares have jumped approximately 112.56%. Shares of the company reached a 52-week high of $11.77 on 10/28/24 and a 52-week low of $3.76 on 01/19/24. A 50-day SMA is recorded $10.01, while a 200-day SMA reached $8.23. Nevertheless, trading volume fell to 0.9 million shares from 1.36 million shares the previous day.
Support And Resistance Levels for Ocular Therapeutix Inc (OCUL)
According to the 24-hour chart, there is a support level at 9.36, which, if violated, would cause prices to drop to 9.24. In the upper region, resistance lies at 9.66. The next price resistance is at 9.85. RSI (Relative Strength Index) is 45.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.27, which suggests the price will decrease in the coming days. Percent R is at 49.70%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
